These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 36094289)

  • 1. Consensus definition of essential, optimal, and suggested components of a pediatric sickle cell disease center.
    Hulbert ML; Manwani D; Meier ER; Alvarez OA; Brown RC; Callaghan MU; Campbell AD; Coates TD; Frei-Jones MJ; Hankins JS; Heeney MM; Hsu LL; Lebensburger JD; Quinn CT; Shah N; Smith-Whitley K; Thornburg C; Kanter J
    Pediatr Blood Cancer; 2023 Jan; 70(1):e29961. PubMed ID: 36094289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What does it mean to be affiliated with care?: Delphi consensus on the definition of "unaffiliation" and "specialist" in sickle cell disease.
    Lamont AE; Hsu LL; Jacobs S; Gibson R; Treadwell M; Chen Y; Lottenberg R; Axelrod K; Varughese T; Melvin C; Smith S; Chukwudozie IB; Kanter J;
    PLoS One; 2022; 17(11):e0272204. PubMed ID: 36367870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comment on: Consensus definition of essential, optimal, and suggested components of a pediatric sickle cell disease center.
    Bodas P; Beck L; Moser B; Delagrange J
    Pediatr Blood Cancer; 2023 May; 70(5):e30205. PubMed ID: 36715136
    [No Abstract]   [Full Text] [Related]  

  • 4. Building access to care in adult sickle cell disease: defining models of care, essential components, and economic aspects.
    Kanter J; Smith WR; Desai PC; Treadwell M; Andemariam B; Little J; Nugent D; Claster S; Manwani DG; Baker J; Strouse JJ; Osunkwo I; Stewart RW; King A; Shook LM; Roberts JD; Lanzkron S
    Blood Adv; 2020 Aug; 4(16):3804-3813. PubMed ID: 32785684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of quality indicators for transition from pediatric to adult care in sickle cell disease: A modified Delphi survey of adult providers.
    Sobota AE; Shah N; Mack JW
    Pediatr Blood Cancer; 2017 Jun; 64(6):. PubMed ID: 27905689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood bank management of sickle cell patients at comprehensive sickle cell centers.
    Afenyi-Annan A; Willis MS; Konrad TR; Lottenberg R
    Transfusion; 2007 Nov; 47(11):2089-97. PubMed ID: 17958539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members.
    Yawn BP; Buchanan GR; Afenyi-Annan AN; Ballas SK; Hassell KL; James AH; Jordan L; Lanzkron SM; Lottenberg R; Savage WJ; Tanabe PJ; Ware RE; Murad MH; Goldsmith JC; Ortiz E; Fulwood R; Horton A; John-Sowah J
    JAMA; 2014 Sep; 312(10):1033-48. PubMed ID: 25203083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying barriers to evidence-based care for sickle cell disease: results from the Sickle Cell Disease Implementation Consortium cross-sectional survey of healthcare providers in the USA.
    Smeltzer MP; Howell KE; Treadwell M; Preiss L; King AA; Glassberg JA; Tanabe P; Badawy SM; DiMartino L; Gibson R; Kanter J; Klesges LM; Hankins JS;
    BMJ Open; 2021 Nov; 11(11):e050880. PubMed ID: 34789492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a New Adult Sickle Cell Disease Center Within an Academic Cancer Center: Impact on Hospital Utilization Patterns and Care Quality.
    Andemariam B; Jones S
    J Racial Ethn Health Disparities; 2016 Mar; 3(1):176-82. PubMed ID: 26896118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of risk factors for an unsuccessful transition from pediatric to adult sickle cell disease care.
    Andemariam B; Owarish-Gross J; Grady J; Boruchov D; Thrall RS; Hagstrom JN
    Pediatr Blood Cancer; 2014 Apr; 61(4):697-701. PubMed ID: 24347402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing barriers and facilitators to transition in sickle cell disease care prior to implementation of a formalized program.
    Sheppard S; Hellemann G; Lebensburger J; Kanter J
    Pediatr Blood Cancer; 2023 Apr; 70(4):e30160. PubMed ID: 36617736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transition from pediatric to adult care in sickle cell disease: establishing evidence-based practice and directions for research.
    Treadwell M; Telfair J; Gibson RW; Johnson S; Osunkwo I
    Am J Hematol; 2011 Jan; 86(1):116-20. PubMed ID: 21061308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute care utilization in pediatric sickle cell disease and sickle cell trait in the USA: prevalence, temporal trends, and cost.
    Peterson EE; Salemi JL; Dongarwar D; Salihu HM
    Eur J Pediatr; 2020 Nov; 179(11):1701-1710. PubMed ID: 32394268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Qualitative Analysis of State Medicaid Coverage Benefits for Allogeneic Hematopoietic Cell Transplantation (alloHCT) for Patients with Sickle Cell Disease (SCD).
    Mupfudze TG; Preussler JM; Sees JA; SanCartier M; Arnold SD; Devine S
    Transplant Cell Ther; 2021 Apr; 27(4):345-351. PubMed ID: 33836889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical trial considerations in sickle cell disease: patient-reported outcomes, data elements, and the stakeholder engagement framework.
    Badawy SM
    Hematology Am Soc Hematol Educ Program; 2021 Dec; 2021(1):196-205. PubMed ID: 34889394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Sickle Cell Disease Ontology: Enabling Collaborative Research and Co-Designing of New Planetary Health Applications.
    Nembaware V; Mazandu GK; Hotchkiss J; Safari Serufuri JM; Kent J; Kengne AP; Anie K; Munung NS; Bukini D; Bitoungui VJN; Munube D; Chirwa U; Chunda-Liyoka C; Jonathan A; Flor-Park MV; Esoh KK; Jonas M; Mnika K; Oosterwyk C; Masamu U; Morrice J; Uwineza A; Nguweneza A; Banda K; Nyanor I; Adjei DN; Siebu NE; Nkanyemka M; Kuona P; Tayo BO; Campbell A; Oron AP; Nnodu OE; Painstil V; Makani J; Mulder N; Wonkam A
    OMICS; 2020 Oct; 24(10):559-567. PubMed ID: 33021900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experiences of African Americans Living With Sickle Cell Disease.
    Wickersham KE; Dawson RM; Becker KP; Everhart KC; Miles HS; Schultz BE; Tucker CM; Wright PJ; Jenerette CM
    J Transcult Nurs; 2022 May; 33(3):334-345. PubMed ID: 35094624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Translating sickle cell guidelines into practice for primary care providers with Project ECHO.
    Shook LM; Farrell CB; Kalinyak KA; Nelson SC; Hardesty BM; Rampersad AG; Saving KL; Whitten-Shurney WJ; Panepinto JA; Ware RE; Crosby LE
    Med Educ Online; 2016; 21():33616. PubMed ID: 27887664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A feasibility study of telemedicine for paediatric sickle cell patients living in a rural medically underserved area.
    Jacob SA; Carroll AE; Bennett WE
    J Telemed Telecare; 2021 Aug; 27(7):431-435. PubMed ID: 31694482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No child left behind: Building a comprehensive sickle cell disease care oasis in the Lake County, Indiana care desert.
    Brown LC; Hampton KC; Bloom EM; Lawson D; Cooper SH; Meier ER
    Pediatr Blood Cancer; 2022 Aug; 69(8):e29619. PubMed ID: 35441446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.